SSRIs and Government Fraud lawsuits may be the most significant issue facing the pharmaceutical industry today. If the government can recover money for the patients it harmed, this lawsuit may be beneficial for these workers. In addition to obtaining a portion of the government’s recovery, this lawsuit will prevent the SSRIs from entering the market. But who will file such a lawsuit? In this article, we will look at the SSRIs, False Claims Act, OMNICARE, and Qui tam laws.
SSRIs, or selective serotonin reuptake inhibitors, are widely prescribed, expensive drugs that cause various side effects. Many of these drugs are covered by government programs for low-income, elderly, and disabled patients. In a False Claims Act lawsuit, companies may be held liable for improper use of government funds. This lawsuit is filed by a whistleblower who reveals illegal activity on behalf of the government. In return for exposing a fraudulent company, the whistleblower can collect a portion of the recovery.
False claims act
While selective serotonin reuptake inhibitors (SSRIs) are only approved for severe depression, they are often prescribed to patients of all levels. Unfortunately, many of these patients are receiving government health care, and that money is destined to pay for these medications. That means a False Claims Act lawsuit could be filed against a company that improperly obtained government funds to make these drugs.
Qui tam law
A qui tam lawsuit is a type of private attorney general case. Unlike traditional lawsuits, qui tams can be filed by citizens who want to bring about change in the government. The FCA allows private citizens to sue on behalf of the government, and whistleblowers are rewarded for their efforts. If you believe you have uncovered a fraudulent scheme, you should consider filing a qui tam lawsuit.
The SSRIs and Government Fraud lawsuit filed against Omnicare alleges that the pharmacy chain submitted false claims to Medicare, Medicaid, and TRICARE for payment for prescriptions filled by doctors who were not affiliated with the company. The company referred to these “rollover” prescriptions as legitimate and then kept dispensing them to patients after they had expired. This fraudulent practice prompted the filing of false claims and was ultimately discovered in 2014.
This CVS Health SSRIs and Government fraud lawsuit were filed in February 2008. The plaintiffs claim that the company violated the terms of the Medicare Part D program by not adequately informing doctors of the financial consequences of switching medications. Further, the lawsuit argues that CVS is not allowed to force patients to switch prescriptions except in specific cases. These include when switching will result in a higher cost or if the patient has already switched prescriptions within two years.
The FDA mandated black-box warnings on SSRIs, but it took many years to get them. It was the collective effort of many people that made this happen, and it should have happened years ago. The drug manufacturers will continue to cover up and blame anything but their drugs. Litigation plays a crucial role in advocating for the victims of SSRIs and raising public awareness of the risks.
CVS Health’s Omnicare business
A federal attorney filed a lawsuit against CVS Health and its subsidiary Omnicare for fraudulently dispensing prescription drugs. Court papers claim that Omnicare’s billing practices involved dispensing drugs without valid prescriptions and falsely billed Medicare and other government health programs. The company is accused of dispensing drugs to patients in group homes, assisted living facilities, and long-term care facilities without the necessary paperwork.